BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Policy

  How to Transition From Academia to Government

  For those looking to transition out of academia, moving into a government role could be one of the most rewarding pathways available.

  April 25, 2023

   · 

  5 min read

   · 

  Eden Whitlock
• 

  Drug Development

  Applied Therapeutics Seeks NDA for Rare Pediatric Disease Drug Despite Phase III Failure

  Govorestat failed its primary composite measure but showed signals of efficacy, leading the company to push forward with an NDA.

  April 25, 2023

   · 

  3 min read

   · 

  Tristan Manalac
• 

  Drug Development

  Bluebird Submits BLA for Sickle-Cell Disease Gene Therapy

  The regulatory filing puts the company alongside Vertex and CRISPR, which also await FDA approval for their SCD gene therapy.

  April 25, 2023

   · 

  4 min read

   · 

  Ashley P. Taylor
• 

  Policy

  FDA Approves Biogen and Ionis’ Qalsody as Fourth-Ever ALS Therapy

  Tuesday, the FDA approved Qalsody—formerly tofersen—on a conditional basis to treat SOD1-ALS.

  April 25, 2023

   · 

  6 min read

   · 

  Heather McKenzie
• 

  Drug Development

  FDA Presses Pause on Another Foghorn Program

  The partial clinical hold follows Foghorn’s voluntary pause of the study and is due to one patient developing irregular heartbeat following treatment with FHD-609.

  April 25, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Drug Development

  Vedanta Raises $106.5M to Advance New Class of C. diff Therapeutics

  Vedanta will use the funds to advance its lead asset VE303 in clostridioides difficile infection and support the development of another candidate in ulcerative colitis.

  April 25, 2023

   · 

  3 min read

   · 

  Tristan Manalac
• Drug Development

  HilleVax Announces Completion of Enrollment of NEST-IN1 Phase 2b Clinical Study of HIL-214 Norovirus Vaccine Candidate

  HilleVax, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, announced completion of enrollment of NEST-IN1, with over 3,000 subjects enrolled in six countries.

  April 25, 2023

   · 

  5 min read
• Business

  3M Announces Senior Management Team Changes

  In connection with the actions announced to streamline the Company and drive greater profitability and growth, 3M has announced the following changes to its senior management team.

  April 25, 2023

   · 

  6 min read
• Business

  GE HealthCare Reports First Quarter 2023 Financial Results

  GE HealthCare, a leading global precision care innovator, reported financial results for the first quarter ended March 31, 2023.

  April 25, 2023

   · 

  31 min read
• Business

  Asensus Surgical Announces Fukuoka Tokushukai Hospital in Japan to Initiate Senhance Surgery Program

  Asensus Surgical, Inc. today announced that Fukuoka Tokushukai Hospital in Kasuga City, Japan has entered into an agreement to lease and utilize a Senhance® Surgical System.

  April 25, 2023

   · 

  5 min read